Turn this role into an interview — a resume and cover letter built around what this employer wants.
Dognosis in Bengaluru seeks a Clinician In-Residence to serve as the medical voice across product, clinical operations, regulatory strategy, patient experience and research as we bring breath-based cancer detection to the world.
This cross-functional role embeds you across study protocols, user experience, and medical affairs; you will shape workflows, support regulatory readiness, and contribute to publications as we prepare for commercial rollout.
Bangalore North, India | Posted on 07/16/2026
Dognosis digitizes canine cognition to detect 30+ human cancers from a single breath sample, with accuracy exceeding standard-of-care diagnostics and at a cost low enough to scale across entire populations.
We're backed by top-tier VCs across India, the US, Israel, and Europe (including Accel India) and have published in the Journal of Clinical Oncology (#1 journal in oncology). We collaborate with UCL, Narayana Health, and Medical Detection Dogs, and have been covered by Scientific American, New Scientist, and Deccan Herald.
As our Clinician In-Residence, you will be the medical voice across product, clinical operations, regulatory strategy, patient experience, and research as we bring breath-based cancer detection to the world.
This is a cross-functional medical role, involving work across product, clinical operations, medical affairs, regulatory, patient experience, and research. Dognosis runs a multi-site prospective clinical study under ICH-GCP and Indian GCP compliance, and is preparing for commercial rollout. You will be embedded across both: shaping protocols and ensuring scientific rigor today, and helping build the medical foundation for a consumer screening product tomorrow.
Nice to have